TORLEY HELEN (PRESIDENT AND CEO) sold 7.6% of their position (60K shares) of HALOZYME THERAPEUTICS, INC. on the open market
Open‑market sale worth $4.17M — a moderate reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
Common Stock
Shares
+20K
Price / share
$8.11
Trade value
$162.20K
% of position
Common Stock
Shares
−19.90K
Price / share
$68.71
Trade value
$1.37M
% of position
Common Stock
Shares
−100.00
Price / share
$69.30
Trade value
$6.93K
% of position
Common Stock
Shares
+20K
Price / share
$8.11
Trade value
$162.20K
% of position
Common Stock
Shares
−4.50K
Price / share
$67.89
Trade value
$305.51K
% of position
Common Stock
Shares
−4K
Price / share
$68.80
Trade value
$275.18K
% of position
Common Stock
Shares
−11.50K
Price / share
$69.73
Trade value
$801.91K
% of position
Common Stock
Shares
+20K
Price / share
$8.11
Trade value
$162.20K
% of position
Common Stock
Shares
−12.72K
Price / share
$70.22
Trade value
$893.03K
% of position
Common Stock
Shares
−6.78K
Price / share
$71.09
Trade value
$482.27K
% of position
Common Stock
Shares
−498.00
Price / share
$71.67
Trade value
$35.69K
% of position
Net shares
+0.00
Net value
-$3.68M
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 11/10/2025 | M · Option Exercise | +20K | $8.11 | $162.20K | 2.7% | 733.72K | 753.72K |
| Common Stock Direct | 11/10/2025 | S · Sale | −19.90K | $68.71 | $1.37M | 2.6% | 753.72K | 733.82K |
| Common Stock Direct | 11/10/2025 | S · Sale | −100.00 | $69.30 | $6.93K | 0.0% | 733.82K | 733.72K |
| Common Stock Direct | 11/11/2025 | M · Option Exercise | +20K | $8.11 | $162.20K | 2.7% | 733.72K | 753.72K |
| Common Stock Direct | 11/11/2025 | S · Sale | −4.50K | $67.89 | $305.51K | 0.6% | 753.72K | 749.22K |
| Common Stock Direct | 11/11/2025 | S · Sale | −4K | $68.80 | $275.18K | 0.5% | 749.22K | 745.22K |
| Common Stock Direct | 11/11/2025 | S · Sale | −11.50K | $69.73 | $801.91K | 1.5% | 745.22K | 733.72K |
| Common Stock Direct | 11/12/2025 | M · Option Exercise | +20K | $8.11 | $162.20K | 2.7% | 733.72K | 753.72K |
| Common Stock Direct | 11/12/2025 | S · Sale | −12.72K | $70.22 | $893.03K | 1.7% | 753.72K | 741K |
| Common Stock Direct | 11/12/2025 | S · Sale | −6.78K | $71.09 | $482.27K | 0.9% | 741K | 734.22K |
| Common Stock Direct | 11/12/2025 | S · Sale | −498.00 | $71.67 | $35.69K | 0.1% | 734.22K | 733.72K |
| Total | +0.00 | -$3.68M | ||||||
Option to Purchase Common Stock
Common Stock
20K shares
Shares
−20K
Strike price
8.11
Held after
56.57K
Exercisable
—
Option to Purchase Common Stock
Common Stock
20K shares
Shares
−20K
Strike price
8.11
Held after
36.57K
Exercisable
—
Option to Purchase Common Stock
Common Stock
20K shares
Shares
−20K
Strike price
8.11
Held after
16.57K
Exercisable
—
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Option to Purchase Common Stock Direct | Common Stock20K shares | 11/10/2025 | M · Option Exercise | −20K | 8.11 | — | 56.57K |
| Option to Purchase Common Stock Direct | Common Stock20K shares | 11/11/2025 | M · Option Exercise | −20K | 8.11 | — | 36.57K |
| Option to Purchase Common Stock Direct | Common Stock20K shares | 11/12/2025 | M · Option Exercise | −20K | 8.11 | — | 16.57K |